Development, optimization, and scale‐up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus‐1

Author:

Shen Chun Fang1ORCID,Burney Elodie1,Gilbert Rénald1,Elahi S. Mehdy1,Parato Kelley1,Loignon Martin1

Affiliation:

1. Human Health Therapeutics Research Centre National Research Council of Canada Montreal Canada

Abstract

AbstractOncolytic viruses (OVs) have emerged as a novel cancer treatment modality, and four OVs have been approved for cancer immunotherapy. However, high‐yield and cost‐effective production processes remain to be developed for most OVs. Here suspension‐adapted Vero cell culture processes were developed for high titer production of an OV model, herpes simplex virus type 1 (HSV‐1). Our study showed the HSV‐1 productivity was significantly affected by multiplicity of infection, cell density, and nutritional supplies. Cell culture conditions were first optimized in shake flask experiments and then scaled up to 3 L bioreactors for virus production under batch and perfusion modes. A titer of 2.7 × 108 TCID50 mL−1 was obtained in 3 L batch culture infected at a cell density of 1.4 × 106 cells mL−1, and was further improved to 1.1 × 109 TCID50 mL−1 in perfusion culture infected at 4.6 × 106 cells mL−1. These titers are similar to or better than the previously reported best titer of 8.6 × 107 TCID50 mL−1 and 8.1 × 108 TCID50 mL−1 respectively obtained in labor‐intensive adherent Vero batch and perfusion cultures. HSV‐1 production in batch culture was successfully scaled up to 60 L pilot‐scale bioreactor to demonstrate the scalability. The work reported here is the first study demonstrating high titer production of HSV‐1 in suspension Vero cell culture under different bioreactor operating modes.

Publisher

Wiley

Subject

Molecular Medicine,Applied Microbiology and Biotechnology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3